Antigen specific T cells in people with obesity at five months following ChAdOx1 COVID-19 vaccination.
Neil E Wrigley KellyConor De BarraFerrah ShaamileAisling HollandLiam ShawPatrick W G MallonJean O'ConnellAndrew E HoganDonal O'SheaPublished in: International journal of obesity (2005) (2022)
These data indicate that PWO who have completed a primary course of ChAdOx1 COVID-19 vaccination have robust, durable, and functional antigen specific T cell immunity that is comparable to that seen in people without obesity.